Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma

被引:285
作者
Pasqualucci, L
Compagno, M
Houldsworth, J
Monti, S
Grunn, A
Nandula, SV
Aster, JC
Murty, VV
Shipp, MA
Dalla-Favera, R [1 ]
机构
[1] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA
[2] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA
[3] Mem Sloan Kettering Canc Ctr, Canc Genet Lab, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[5] MIT, Broad Inst, Cambridge, MA 02141 USA
[6] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
10.1084/jem.20052204
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
PR domain containing 1 with zinc finger domain (PRDM1)/B lymphocyte-induced maturation protein 1 (BLIMP1) is a transcriptional repressor expressed in a subset of germinal center (GC) B cells and in all plasma cells, and required for terminal B cell differentiation. The BLIMP1 locus lies on chromosome 6q21-q22.1, a region frequently deleted in B cell lymphomas, suggesting that it may harbor a tumor suppressor gene. We report here that the BLIMP1 gene is inactivated by structural alterations in 24% (8 out of 34) activated B cell-like diffuse large cell lymphoma (ABC-DLBCL), but not in GC B cell-like (n = 0/37) or unclassified (n = 0/21) DLBCL. BLIMP1 alterations included gene truncations, nonsense mutations, frameshift deletions, and splice site mutations that generate aberrant transcripts encoding truncated BLIMP1 proteins. In all cases studied, both BLIMP1 alleles were inactivated by deletions or mutations. Furthermore, most non-GC type DLBCL cases (n = 20/26, 77%) lack BLIMP1 protein expression, despite the presence of BLIMP1 mRNA. These results indicate that a sizable fraction of ABC-DLBCL carry an inactive BLIMP1 gene, and suggest that the same gene is inactivated by epigenetic mechanisms in an additional large number of cases. These findings point to a role for BLIMP1 as a tumor suppressor gene, whose inactivation may contribute to lymphomagenesis by blocking post-GC differentiation of B cells toward plasma cells.
引用
收藏
页码:311 / 317
页数:7
相关论文
共 27 条
[1]   Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach [J].
Abramson, JS ;
Shipp, MA .
BLOOD, 2005, 106 (04) :1164-1174
[2]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[3]   Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo [J].
Angelin-Duclos, C ;
Cattoretti, G ;
Lin, KI ;
Calame, K .
JOURNAL OF IMMUNOLOGY, 2000, 165 (10) :5462-5471
[4]   Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction [J].
Bea, S ;
Zettl, A ;
Wright, G ;
Salaverria, I ;
Jehn, P ;
Moreno, V ;
Burek, C ;
Ott, G ;
Puig, X ;
Yang, LM ;
Lopez-Guillermo, A ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Gascoyne, RD ;
Connors, JM ;
Grogan, TM ;
Braziel, R ;
Fisher, RI ;
Smeland, EB ;
Kvaloy, S ;
Holte, H ;
Delabie, J ;
Simon, R ;
Powell, J ;
Wilson, WH ;
Jaffe, ES ;
Montserrat, E ;
Muller-Hermelink, HK ;
Staudt, LM ;
Campo, E ;
Rosenwald, A .
BLOOD, 2005, 106 (09) :3183-3190
[5]   PRDM1/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage [J].
Cattoretti, G ;
Angelin-Duclos, C ;
Shaknovich, R ;
Zhou, HP ;
Wang, DO ;
Alobeid, B .
JOURNAL OF PATHOLOGY, 2005, 206 (01) :76-86
[6]  
DALLAFAVERA R, 2003, NONHODGKINS LYMPHOMA, P825
[7]  
FEARON ER, 2002, GENETIC BASIS HUMAN, P197
[8]   DELETIONS INVOLVING 2 DISTINCT REGIONS OF 6Q IN B-CELL NON-HODGKIN LYMPHOMA [J].
GAIDANO, G ;
HAUPTSCHEIN, RS ;
PARSA, NZ ;
OFFIT, K ;
RAO, PH ;
LENOIR, G ;
KNOWLES, DM ;
CHAGANTI, RSK ;
DALLAFAVERA, R .
BLOOD, 1992, 80 (07) :1781-1787
[9]   Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines [J].
Györy, I ;
Fejér, G ;
Ghosh, N ;
Seto, E ;
Wright, KL .
JOURNAL OF IMMUNOLOGY, 2003, 170 (06) :3125-3133
[10]   Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray [J].
Hans, CP ;
Weisenburger, DD ;
Greiner, TC ;
Gascoyne, RD ;
Delabie, J ;
Ott, G ;
Müller-Hermelink, HK ;
Campo, E ;
Braziel, RM ;
Jaffe, ES ;
Pan, ZG ;
Farinha, P ;
Smith, LM ;
Falini, B ;
Banham, AH ;
Rosenwald, A ;
Staudt, LM ;
Connors, JM ;
Armitage, JO ;
Chan, WC .
BLOOD, 2004, 103 (01) :275-282